Clinical Cardiology Alert – January 1, 2008
January 1, 2008
View Issues
-
A Better Antiplatelet Drug?
Many efforts are underway to develop reliable and effective antiplatelet agents that have a minimal risk for bleeding. -
Warfarin vs Clopidogrel Plus Aspirin for Atrial Fibrillation
The atrial fibrillation clopidogrel trial with Irbesartan for Prevention of Vascular Events (ACTIVE W) is a noninferiority trial comparing anticoagulation with warfarin to therapy with aspirin plus clopidogrel for stroke prevention in patients with atrial fibrillation. -
Carotid Disease and CABG
The management of patients with significant carotid artery disease, who need coronary artery bypass surgery (CABG), especially if the carotid disease is asymptomatic, is controversial. In the absence of randomized trials, this report of carotid artery stenting followed by CABG in 356 patients with severe asymptomatic carotid disease is of interest. -
Driving and ICD Shocks for Ventricular Arrhythmias
The triggers of ventricular arrhythmia (tova Study) was a multicenter, prospective, cohort study that examined lifestyle and psychological triggers that might result in implantable cardioverter-defibrillator (ICD) shocks for ventricular tachycardia (VT) or ventricular fibrillation (VF). -
Biomarker in Peripheral Arterial Disease
Peripheral arterial disease (PAD) is an exceedingly common manifestation of atherosclerosis. Its presence heralds an increased risk for death from coronary artery disease (CAD) and stroke, yet it continues to go unrecognized in a large proportion of patients. -
Pharmacology Watch
FDA warnings for existing drugs dominate pharmaceutical news this month. -
Clinical Briefs in Primary Care Supplement